Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-22-000150
Filing Date
2022-02-03
Accepted
2022-02-03 15:53:10
Documents
1
Group Members
BRENDAN O'NEILKEITH COULSTON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g082598_sch13ga.htm SC 13G/A 69548
  Complete submission text file 0001753926-22-000150.txt   71078
Mailing Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123
Business Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123 415-999-2132
Ionic Ventures, LLC (Filed by) CIK: 0001769419 (see all company filings)

EIN.: 660889836 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92867 | Film No.: 22588119
SIC: 2834 Pharmaceutical Preparations